Skip to content

Clinical trials

Completed Stomach Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Status: Completed Country / region: Japan Clear all

89 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20025
20031
20041
20055
20064
20074
20087
20096
20102
20115
20122
20134
20145
20152
20166
20175
20189
20191
20201
20211
20223
20234
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed89

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC5
Pfizer5
Taiho Pharmaceutical Co., Ltd.5
Amgen4
AstraZeneca4
Eli Lilly and Company4
Japan Clinical Oncology Group4
Japan Clinical Cancer Research Organization3
Novartis Pharmaceuticals3
Ono Pharmaceutical Co., Ltd.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms89
Neoplasms9
Carcinoma, Non-Small-Cell Lung6
Ovarian Neoplasms6
Carcinoma, Hepatocellular4
Cholangiocarcinoma4
Neoplasm Metastasis4
Small Cell Lung Carcinoma4
Triple Negative Breast Neoplasms4
Esophageal Neoplasms3

Trials

Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.